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In this study, the association between genotypic and selected phenotypic characteristics was examined in a
collection of Canadian Escherichia coli O157:H7 strains isolated from humans and cattle in the provinces of
Alberta, Ontario, Saskatchewan, and Quebec. In a subset of 69 strains selected on the basis of specific phage
types (PTs), a strong correlation between the lineage-specific polymorphism assay (LSPA6) genotype and PT
was observed with all strains of PTs 4, 14, 21, 31, 33, and 87 belonging to the LSPA6 lineage I (LSPA6-LI)
genotype, while those of PTs 23, 45, 67, and 74 belonged to LSPA6 lineage II (LSPA6-LII) genotypes. This
correlation was maintained when additional strains of each PT were tested. E. coli O157:H7 strains with the
LSPA6-LI genotype were much more common in the collection than were the LSPA6-LII or lineage I/II
(LSPA6-LI/II)-related genotypes (82.6, 11.2, and 5.8%, respectively). Of the strains tested, proportionately
more LSPA6-LI than LSPA6-LII genotype strains were isolated from humans (52.7% versus 19.7%) than from
cattle (47.8% versus 80.2%). In addition, 96.7% of the LSPA6-LII strains carried the stx2c variant gene, while
only 50.0% of LSPA6-LI/II and 2.7% of LSPA6-LI strains carried this gene. LSPA6-LII strains were also
significantly more likely to possess the colicin D gene, cda (50.8% versus 23.2%), and have combined resistance
to streptomycin, sulfisoxazole, and tetracycline (72.1% versus 0.9%) than were LSPA6-LI strains. The LSPA6
genotype- and PT-related characteristics identified may be important markers of specific ecotypes of E. coli
O157:H7 that have unique epidemiological and virulence characteristics.
Shiga toxin (Stx)-producing Escherichia coli (STEC)
O157:H7 is the leading cause of hemorrhagic colitis and he-
molytic-uremic syndrome (HUS) throughout the world (16, 23,
25). Cattle colonized by E. coli O157:H7 are thought to be the
primary reservoir of this bacterium, and its transmission to
humans frequently results from the ingestion of contaminated
food and water (16, 23, 35).
Results of multiple studies suggest that E. coli O157:H7
strains may differ in their association with human disease. An
increasing body of evidence has shown that strains can differ in
the type and level of expression of virulence factors (3, 28, 29,
47, 48). Similarly, in vivo testing of strains in the gnotobiotic
pig model has shown that human isolates caused more severe
symptoms than cattle isolates, suggesting that cattle-derived
strains may differ in their virulence with respect to those iso-
lated from humans (3). High-resolution genotyping studies on
E. coli O157:H7 strains from the United States and Australia
using octamer-based genome scanning (OBGS) first demon-
strated that the E. coli O157:H7 clonal complex has diverged
through two primary lineages, designated lineage I and lineage
II, and that these two lineages differ in their frequency of
association with human disease (28, 29, 54). Subsequent stud-
ies using a more efficient multiplex PCR assay based on OBGS,
the lineage specific polymorphism assay (LSPA6), among a
collection of 1,400 E. coli O157:H7 strains from the United
States, showed that although lineage I (LSPA6 genotype
111111) was the most common genotype isolated from humans
or cattle, it was proportionately overrepresented among hu-
man isolates. In contrast, lineage II (LSPA6 genotype 222222)
occurred at a significantly higher frequency among bovine
strains than among human strains. The authors of these studies
suggest that E. coli O157 lineage II strains may be less virulent
for humans than lineage I strains (54). Recent studies which
demonstrate that the genomic island and prophage content of
lineage I and II strains differ support this contention (5, 30,
55). Further, the levels of expression of certain genes, includ-
ing some of those associated with virulence, such as stx2, also
appear to differ between strains of the two lineages (30). Taken
together, these multiple lines of evidence suggest that geno-
typic differences between the two lineages underlie apparent
phenotypic differences in virulence and host ecology.
The purpose of the present study was to examine whether
the genotypic differences between E. coli O157:H7 OBGS/
LSPA lineages are correlated with phenotypic differences that
may help to explain known differences in their epidemiology/
host ecology. Strains isolated from human and cattle sources
were genotyped using OBGS and LSPA-6 and were character-
ized for a range of phenotypic characteristics, including phage
* Corresponding author. Mailing address: Laboratory for Food-
borne Zoonoses, Public Health Agency of Canada, C/O CFIA Leth-
bridge Laboratory, Box 640, Townshiproad 9-1, Lethbridge, Alberta
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TABLE 1. E. coli O157:H7 strains characterized in this study
Strain Set no. PT LSPA6 genotypea Lineageb Origin Strain Set no. PT LSPA6 genotypea Lineageb Origin
ECI-1382 1 1 111111 I Bovine ECI-327 1 14 111111 I Human
ECI-665 1 1 111111 I Bovine ECI-351 1 14 111111 I Human
ECI-282 1 1 111111 I Human ECI-377 1 14 111111 I Human
1557 2 1 111111 I Bovine ECI-485 1 14 111111 I Human
00301Fe036.1 2 1 111111 I Bovine ECI-529 1 14 111111 I Human
0106-1 2 1 111111 I Bovine ECI-543 1 14 111111 I Human
07101Fe031.2 2 1 111111 I Bovine ECI-853 1 14 111111 I Human
07101Fe036.01 2 1 111111 I Bovine R1832/99-1 1 14 111111 I Human
A533 2 1 111111 I Bovine 09301Fe058.1 2 14 111111 I Bovine
bb4-1 2 1 111111 I Bovine 10801Fe022.2 2 14 111111 I Bovine
c199-2-472 2 1 111111 I Bovine ECI-871 2 14 111111 I Human
ec20010334 2 1 111111 I Bovine ER5769 2 14 111111 I Human
F156DB 2 1 111111 I Bovine KPCA-4-1 1 21 111111 I Bovine
ECI-243 2 1 111111 I Human ECI-247 2 21 111111 I Human
ECI-882 2 1 211111 I/II Human ECI-508 2 21 111111 I Human
ER1728 2 1 222121 II Human ER3199-2 2 21 111111 I Human
LRC.319 2 1 111111 I Human ER6931 2 21 111111 I Human
M01MD3000 2 1 111111 I Human ECI-1433 1 23 222222 II Bovine
278F1 1 2 211111 I/II Human ECI-633 1 23 222222 II Bovine
C69F1 1 2 211111 I/II Bovine 03601Fe029.2 2 23 222222 II Bovine
ECI-497 1 2 211111 I/II Human 05301Fe029.2 2 23 222222 II Bovine
ECI-504 1 2 211111 I/II Human 05401Fe004.2 2 23 222222 II Bovine
09601Fe010.1 2 2 211111 I/II Bovine 06801Fe023.1 2 23 222222 II Bovine
B147-3-413 2 2 211111 I/II Bovine 06901Fe002.1 2 23 222222 II Bovine
ER1941 2 2 211111 I/II Human 07501Fe007.1 2 23 222222 II Bovine
ER5767 2 2 211111 I/II Human 09701Fe007.1 2 23 222222 II Bovine
ECI-577 1 4 111111 I Bovine 104P1(IMS) 2 23 222222 II Bovine
ECI-846 1 4 111111 I Human 113-X-9A 2 23 222222 II Bovine
R82F2(P) 1 4 111111 I Human 666-X-5-1-R2 2 23 222222 II Bovine
E622-1 2 4 111111 I Bovine 85-C-5D 2 23 222222 II Bovine
ER2966 2 4 111111 I Human CG29-1 2 23 222222 II Bovine
H112-2 2 4 111111 I Human ECI-1435 2 23 222222 II Bovine
LRC.E318N 2 4 111111 I Human ECI-564 2 23 222222 II Bovine
EC01-296 1 8 111111 I Bovine ECI-672 2 23 222222 II Bovine
99-4367 1 8 111111 I Human ECI-684 2 23 222222 II Bovine
00102Fe040.2 2 8 211111 I/II Bovine F12 DIRECT 2 23 222222 II Bovine
02601Fe041.1 2 8 111111 I Bovine F203 DB 2 23 222222 II Bovine
02701Fe070.1 2 8 211111 I/II Bovine 666-H-4-1 2 23 222222 II Human
03301Fe011.2 2 8 111111 I Bovine ECI-306 2 23 222222 II Human
04601Fe023.1 2 8 111111 I Bovine ECI-886 2 23 222222 II Human
07501Fe027.1 2 8 111111 I Bovine ER3192 2 23 222222 II Human
09401Fe052.2 2 8 111111 I Bovine ER6554 2 23 222222 II Human
09501Fe030.2 2 8 211111 I/II Bovine 0077P1 1 31 111111 I Bovine
09701Fe053.1 2 8 111111 I Bovine ECI-579 1 31 111111 I Bovine
3D-1-1 2 8 111111 I Bovine ECI-212 1 31 111111 I Human
ECI-2128 2 8 111111 I Bovine ECI-310 1 31 111111 I Human
EC20040003 2 8 111111 I Human ECI-880 1 31 111111 I Human
ER3762 2 8 111111 I Human 10001Fe065.2 2 31 111111 I Bovine
ER4073 2 8 111111 I Human 11701Fe002.1 2 31 111111 I Bovine
ER4102-1 2 8 111111 I Human ER3312 2 31 111111 I Human
ER4104 2 8 111111 I Human ER5019 2 31 111111 I Human
ER5533 2 8 111111 I Human ECI-653 1 32 111111 I Bovine
ER5850 2 8 111111 I Human ECI-291 1 32 111111 I Human
ER6066 2 8 111111 I Human ER2933 2 32 111111 I Human
M01MD3094 2 8 111111 I Human ER5697 2 32 211111 I/II Human
EC01-1243 1 14 111111 I Bovine 192P1 1 33 111111 I Bovine
EC01-129 1 14 111111 I Bovine EC01-1228 1 33 111111 I Bovine
EC01-142 1 14 111111 I Bovine ECI-221 1 33 111111 I Human
ECI-1330 1 14 111111 I Bovine ECI-881 2 33 111111 I Human
ECI-1375 1 14 111111 I Bovine ER6321 2 33 111111 I Human
ECI-1396 1 14 111111 I Bovine ER6423 2 33 111111 I Human
ECI-1479 1 14 111111 I Bovine ECI-600 1 34 111111 I Bovine
ECI-563 1 14 111111 I Bovine 99-4408 1 34 111111 I Human
ECI-589 1 14 111111 I Bovine 29-X-13C-R3 2 34 232222 II Bovine
ECI-606 1 14 111111 I Bovine ec19920027 2 34 212222 II Bovine
ECI-624 1 14 111111 I Bovine ECI-2152 2 34 222213 II Bovine
ECI-642 1 14 111111 I Bovine eci-2153 2 34 212232 II Bovine
ECI-657 1 14 111111 I Bovine ECI-270 2 34 111111 I Human
ECI-681 1 14 111111 I Bovine ER5707 2 34 111111 I Human
271F1 1 14 111111 I Human ECI-357 1 45 222222 II Human
279f1 1 14 111111 I Human 01301Fe007.1 2 45 222222 II Bovine
98-2724 1 14 111111 I Human 07901Fe003.2 2 45 222222 II Bovine
98-5734 1 14 111111 I Human CG16-2A 2 45 222222 II Bovine
99-4285 1 14 111111 I Human CG9-1 2 45 222222 II Bovine
99-4360 1 14 111111 I Human E275 2 45 222222 II Bovine
ECI-219 1 14 111111 I Human E294 2 45 232212 II Bovine
ECI-250 1 14 111111 I Human IE252 2 45 222222 II Bovine
ECI-278 1 14 111111 I Human IE292 2 45 222222 II Bovine
ECI-309 1 14 111111 I Human IE297 2 45 222222 II Bovine
ECI-320 1 14 111111 I Human RECDE291 2 45 222222 II Bovine
Continued on following page
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type (PT), type and level of Stx production, colicin genes, and
antimicrobial resistance (AMR), in order to examine any po-
tential associations between lineage and phenotype. The re-
sults show a strong correlation between lineage and PT and a
biased distribution of stx genotype, colicin content, and AMR.
Our findings provide further evidence for the differentiation of
physiological, ecological, and virulence characteristics between
the two primary lineages of E. coli O157:H7 and suggest that
these characteristics may be useful epidemiological markers.
MATERIALS AND METHODS
Bacterial strains. Initially, 69 E. coli O157:H7 strains (set 1), comprising 37
strains from humans and 32 strains from cattle, were selected from the culture
collection of the Laboratory for Food-Borne Zoonoses based on their PT (Table
1). These strains had been isolated from the provinces of Alberta, Ontario,
Saskatchewan, and Quebec. A total of 43 additional human strains and 75
additional bovine strains were subsequently included to examine certain trends
that became evident after initial analysis of set 1. Altogether, 187 test strains
comprising 80 human and 107 bovine sources were selected (Table 1). In addi-
tion, 10 E. coli O157:H7 reference strains of known OBGS and LSPA6 type (28)
were used in the study as positive controls in the LSPA6 and OBGS studies
(Table 2). All strains were stored at 70°C in brain heart infusion broth (Difco)
with 15% glycerol. When required, the strains were grown in 1 ml of brain heart
infusion broth overnight at 37°C.
Phage typing and virulence gene profiling. PTs were determined for all of the
strains as described previously (1, 26). All of the strains were tested by PCR to
determine their Shiga toxin (stx) type, the presence of the EHEC hemolysin
(ehxA) and the attaching and effacing genes (eaeA) (40, 57). Set 1 strains were
stx2 subtyped (4). Since the method used for stx2 subtyping does not differentiate
between stx2c, stx2da, and stx2v(521) (57), all strains were tested by an stx2c-specific
PCR developed by Rolgaard and coworkers that successfully detected 97% of
Stx2c-producing O157:H7 strains (B. Rolgaard, unpublished data). The primer
sequences were designed to specifically target genes upstream of the stx gene,
namely, the q and ileZ genes encoded by the Stx phages, 933w (stx2) and Nil2
(stx2c). The primer sequences were as follows: the qNil2 forward primer, 5-TGC
CGA CGG GAA GTT GAC-3; the q933w forward primer, 5-GGC GGC AAA
TAA CTA TGA GG-3; and the ileZ reverse primer, 5-AGC GAC CTG GCG
ATT ATG AG-3. Briefly, each 25-l reaction mixture contained 5 l of cell
template, 1 PCR buffer (50 mM KCl, 10 mM Tris-HCl [pH 8.3], 1.5 mM
MgCl2, and 0.01% [wt/vol] gelatin; Applied Biosystems, Foster City, CA), 200
M concentrations of each deoxynucleoside triphosphate (Applied Biosystems),
each primer at a concentration of 0.5 M, and 0.1 U of AmpliTaq (Applied
Biosystems)/l. Amplification was conducted at 94°C for 4 min, followed by 30
cycles of 94°C for 30 s, 47.0°C for 60 s, and 72°C for 90 s. Products of 478 and 886
bp were produced for the O157:H7 strains containing stx2c and stx2, respectively.
The presence of the colicin genes K, V, B, and M was determined on set 1
strains by using previously described PCR assays (21, 50). Colicins Ia/Ib and
E2/E3/E6/E7 genes were detected in set 1 strains by PCR using previously
described primers (50) with the following conditions: each 25-l PCR mixture
contained 1 l of cell template, 1 Gold buffer (Applied Biosystems) 1 M
concentrations of each primer, 0.2 mM concentration of each deoxynucleotide
triphosphate (Applied Biosystems), 1 mM MgCl2, and 0.036 U of AmpliTaq
Gold (Applied Biosystems). Thermal cycling conditions were the same as in the
published report (50) except that the initial denaturation step was at 94°C for 10
min. The presence of the colicin D gene, cda, was determined on all test strains
by PCR, as previously described (21).
LSPA6 and OBGS typing. All strains were typed by the LSPA6 method as two
reactions rather than the one multiplex reaction as originally described (54). The
LSPA6 primer sequences used in the present study are listed in Table 3. One
multiplex reaction contained folD, Z5935, rbsB, and arp primers and the second
multiplex reaction contained yhc and rtcB primers. Lysates for PCRs were pre-
pared by boiling washed cells (44). Amplification reactions contained 4 l of the
cell lysate combined with 16 l of the mastermix that consisted of 1 PCR buffer
(50 mM KCl, 10 mM Tris-HCl [pH 8.3], 1.5 mM MgCl2 and 0.01% [wt/vol]
gelatin), 250 M concentrations of each deoxynucleoside triphosphate, each
primer at a concentration of 0.5 M, and 0.05 U of AmpliTaq (Applied Biosys-
tems)/l. Amplification was conducted at 94°C for 5 min, followed by 30 cycles
of 94°C for 30 s, 52.2°C for 30 s, and 72°C for 45 s. Aliquots (5 l) of the amplified
products were analyzed by standard submarine gel electrophoresis using a 3%
Metaphor agarose gel (Cambrex, Rockland, ME) stained with ethidium bromide,
and the bands visualized with UV transillumination. Images of the amplicon gel
profiles were captured by using a Gel Doc 100 (Bio-Rad, Mississauga, Ontario,
Canada) and analyzed in Bionumerics (version 3.5; Applied Maths, Austin, TX).
LSPA6 alleles and genotypes were defined by using a binary character table
that was generated in Bionumerics and exported to Microsoft Excel. Alleles
shared with the lineage I control strain were designated 1, and those shared with
the lineage II control strain were designated 2. Unique alleles were designated 3,
and a zero character was assigned if no band was present. To generate the
genotype classification, the alleles were placed in the following order: folD,
Z5935 gene, yhcG, rtcB, rbsB, and arp-iclR.
Thirty-five strains from set 1 were also tested by traditional OBGS, using
the primer pairs KOCT22A/KOCT6C, KOCT21/KOCT13C, KOCT19/6C,
KOCT3B/KOCT4C, and KOCT14/KOCT1C. The OBGS reference strains were
included in each gel. Binary files were created in Microsoft Excel from printed
TABLE 1—Continued
Strain Set no. PT LSPA6 genotypea Lineageb Origin Strain Set no. PT LSPA6 genotypea Lineageb Origin
ECI-509 2 45 222222 II Human 07101FE041.2 2 74 232212 II Bovine
ECI-240 1 54 222213 II Human C55-2B 2 74 232212 II Bovine
02001Fe052.1 2 54 222213 II Bovine EC01-1097 2 74 222222 II Bovine
K114D1 1 67 222222 II Bovine F136 DB 2 74 222212 II Bovine
08401Fe026.1 2 67 222223 II Bovine ECI-242 2 74 212222 II Human
08401Fe054.1 2 67 222223 II Bovine ER4511 2 74 232212 II Human
114-X-3B-R1 2 67 222222 II Bovine EC01-1139 1 82 222222 II Bovine
29-C-3A 2 67 222222 II Bovine ECI-603 1 87 111111 I Bovine
K124A-K-1 2 67 222222 II Bovine herd 166DB 1 87 111111 I Bovine
K124D1 2 67 222222 II Bovine ECI-558 1 87 111111 I Human
ECI-331 2 67 222222 II Human CO-9283 2 87 111111 I Bovine
F136 1 74 222212 II Bovine ECI-1258 2 87 111111 I Bovine
ECI-241 1 74 222212 II Human F1084 2 87 111111 I Bovine
06501FE02.1 2 74 232212 II Bovine
a LSPA6 genotype (54).
b Predicted OBGS lineage derived from LSPA6 genotype result (28).
TABLE 2. E. coli O157:H7 LSPA6 reference strains
Strain LSPA6a Origin PT Lineageb
FRIK920 222222 Bovine 23 II
FRIK1985 222223 Bovine 45 II
FRIK1990 222222 Bovine 54 II
FRIK1999 222222 Bovine 23 II
FRIK2001 222213 Bovine 54 II
93-001 111111 Human 14 I
FRIK523 111111 Human 34 I
FDA516 111111 Human 21 I
FDA518 111111 Human 21 I
FDA520 111111 Human 1 I
MC1061 (K-12)
a LSPA6 (lineage specific polymorphism assay) genotype (54).
b Predicted OBGS lineage derived from LSPA6 genotype result (28).
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copies of the images produced by an Alden 9315CTP photographic quality
thermal printer (Alden Electronics, Westborough, MA). The files were gener-
ated from the presence or absence of bands between 200 and 1,500 bp. The
lineage designation was obtained by comparison of the binary strings of each
sample to the binary string of the OBGS reference strains.
All strains that were LSPA6 genotype 111111 were classified as lineage I. Most
other allele combinations corresponded to OBGS lineage II. LSPA6 genotype
211111 was originally considered a lineage II strain (54), but recent reports
indicate that LSPA6 genotype 211111 strains have characteristics of both lineage
I (LSPA6 111111) and lineage II strains (52, 55). Accordingly, LSPA6 genotype
211111 was designated as lineage I/II and was not considered a lineage II LSPA6
genotype in the strain comparisons for the present study.
Shiga toxin production. The levels of Stx2 produced by a subset of strains were
quantified by using a Stx–enzyme-linked immunosorbent assay (Stx-ELISA) with
monoclonal antibodies that recognize Stx2, Stx2c, Stx2d, and Stx2e variants (2).
Quantification was achieved by generation of a standard curve with known
concentrations of purified Stx2. The results were recorded as picograms of toxin
per 108 CFU. Cultures were prepared with or without induction by mitomycin C
as previously described (46) except that 1 ml of the cells were lysed by incubation
at 37°C for 5 min after the addition of a warm solution of polymyxin B (Sigma)
to a concentration of 1.5 mg/ml rather than by sonication.
Antimicrobial resistance testing. Antimicrobial resistance was determined as
previously described (42) using the following antibiotics and their respective
concentrations: amikacin (16 g/ml), ampicillin (32 g/ml), carbadox (30 g/ml),
cefotaxime (64 g/ml), cefoxitin (32 g/ml), ceftiofur (8 g/ml), ceftriaxone (8
g/ml), cephalothin (32 g/ml), chloramphenicol (32 g/ml), ciprofloxacin
(0.125, g/ml), cotrimoxazole (80 g/ml: sulfisoxazole and trimethoprim at 76
and 4 g/ml, respectively), florfenicol (16 g/ml), gentamicin (16 g/ml), kana-
mycin (64 g/ml), nalidixic acid (32 g/ml), nitrofurantoin (64 g/ml), spectino-
mycin (64 g/ml), streptomycin (64 g/ml), sulfisoxazole (512 g/ml), tetracy-
cline (16 g/ml), tobramycin (8 g/ml), and trimethoprim (16 g/ml). These
antibiotics were chosen since they are or have been used therapeutically in
veterinary or human medicine or as growth promoters in animal agriculture and
may provide a selective advantage to resistant strains. Quality control strains
included American Type Culture Collection (ATCC) strains Pseudomonas
aeruginosa ATCC 27853, E. coli ATCC 25922, and E. coli ATCC 35218 (36, 37),
as well as E. coli strain R1022, a multiresistant bovine isolate.
Plasmid profiling. Plasmid DNA was isolated by the method of Crosa and
Falkow (10), except that the strains were grown overnight on veal infusion yeast
extract agar, scraped off the surface of the agar with a sterile toothpick, and
suspended in lysis buffer (pH 12.4). The plasmid DNA was subjected to electro-
phoresis in a horizontal 0.7% agarose gel in Tris-acetate buffer and stained with
ethidium bromide, and the bands were visualized by UV transillumination. Im-
ages were captured by using a Gel Doc 100 (Bio-Rad). Plasmids from PT 31 and
PT 33 strains of E. coli O157:H7 appeared to be degraded by nucleases. For these
strains, the addition of 50 M thiourea (Sigma) to the running buffer was used
to protect against degradation (43).
Statistical analysis. All pairwise associations between LSPA6 genotypes, PTs,
the presence of stx2c and cda genes, and AMR were tested by using the Fisher
exact test (http://www.matforsk.no/ola/fisher.htm). (For a comprehensive listing
of P values, see Tables S1, S2, and S3 in the supplemental material.)
RESULTS AND DISCUSSIONS
Distribution of LSPA6 and OBGS types. In order to exam-
ine the frequency of specific LSPA6 types in the collection of
E. coli O157:H7 strains, an initial subset of 69 strains (set 1,
Table 1) was selected based on the approximate proportions of
each PT in our collection (Table 1). PT 14 was the most
common PT in the collection, which is consistent with what has
previously been reported for Canada (11). The other 16 PTs
included: 1, 2, 4, 8, 21, 23, 31, 32, 33, 34, 45, 54, 67, 74, 82, and
87. Among the 69 strains, five LSPA6 genotypes were identi-
fied: 57 (82.6%) were of LSPA6 genotype 111111 (LSPA6-LI),
while the remaining 12 (17.4%) strains were of other LSPA6
genotypes. These included four (5.8%) LSPA6 genotype
211111 (LSPA6-LI/II) strains, five (7.2%) LSPA6 genotype
222222 strains, two (2.9%) genotype 222212 strains, and one
(1.4%) genotype 222213 strain. LSPA6 and OBGS typing re-
sults from the 35 strains tested by both methods agreed with
respect to lineage designation, with the exception of three
strains that could not be typed by the OBGS method but which
were resolved by LSPA6 typing (data not shown).
Association between LSPA6 type, PT, and source of isola-
tion. A strong association between PT and LSPA6 genotype
was observed in the 69 strains from set 1 (Table 1). However,
certain PTs had very few representatives, and additional strains
of the same PTs were selected at random from the larger
collection of E. coli O157:H7 strains to further examine this
association. In this expanded set of strains, PTs 4, 14, 21, 31, 33,
and 87 were all genotype LSPA6 111111 (LSPA6-LI), while
three PTs (45, 67, and 74) had minor differences in LSPA6
genotypes but remained within lineage II (e.g., PT 67 had six
strains of LSPA6 genotype 222222 and two of LSPA6 genotype
222223) (Fig. 1). Two PTs (PT 8 and PT 32) had strains of
LSPA6 111111 and 211111. Only 2 of 17 PTs (PT 1 and PT 34)
had strains from both LSPA6-LI and LSPA6-LII genotypes.
To the best of our knowledge, this is the first time that an
association has been demonstrated between PT and LSPA6
genotype.
Within this expanded set of strains, the LSPA6-LI genotype
made up 73.8% (59 of 80) and 49.5% (53 of 107) of E. coli
O157:H7 strains isolated from human and bovine sources, re-
spectively (Fig. 2). The relative overrepresentation of
LSPA6-LI among human isolates was also observed by Yang et
al. (54) in their study of a large collection of bovine and human
isolates. Nine LSPA6-LI/II (211111) genotype strains were of
human origin and five were of bovine origin. LSPA6-LII ge-
notypes represented 15.0% (12 of 80) of the isolates from
humans (222222, 222212, 222213, 232212, 212222, and 222121)
and 45.8% (49 of 107) of the isolates from cattle (222222,
222223, 222212, 222213, 232212, 212222, 212232, 222121,
232222, and 232212). The bovine source bias among LSPA6-
LII genotypes was highly significant (Fisher exact test; P 
8.047  106). Certain lineage II-related PTs such as PT 23
also had a significant (Fisher exact test; P  1.681  102)
bovine host isolation bias. The strong association between PT
TABLE 3. LSPA6 PCR primer sequences
Primer Sequence (5–3)
Predicted
product
length
(bp)
Source or
reference
folD-F TAC GTA GGT CGA AGG G 161 or 170 54
folD-R CCA GAT TTA CAA CGC C
Z5935-F GTG TTC CCG GTA TTT G 133 or 142 54
Z5935-R CTC ACT GGC GTA ACC T
yhcG-F CTC TGC AAA AAA CTT
ACG CC
142 or 219 54
yhcG-R AAC GGA AAG TAA ACG
GAC G
This study
rbsB-F AGT TTA ATG TTC TTG
CCA GCC
209 or 218 54
rbsB-R ATT CAC CGC TTT TTC
GCC
rtcB-F GCG CCA GAT CGA TAA
AGT AAG
270 or 279 54
rtcB-R GCC GTT GTA AAC GTG
ATA AAG
arp-iclR-F GCT CAA TCT CAT AAT
GCA GCC
279 or 288 54
arp-iclR-R GCG ATG GTG ATT AAA
GCG G
This study
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and LSPA6 genotype suggests that some PT/LSPA6 genotype
combinations are stable, although further investigation will be
required to explore whether this association is widespread.
Association between LSPA6 genotype, PT, Stx2 genotype,
and toxin production. Considerable variation was found
among LSPA6 genotypes in stx gene content and stx2 genotype.
stx1 and stx2 were identified in 79% of strains tested, stx2 alone
was present in 17% of the strains, stx1 alone was present in 3%
of the strains, and one strain did not contain either toxin-
producing gene. The stx2c variant was detected by the stx2c
specific PCR in 59 of 61 LSPA6-LII strains (96.7%). An addi-
tional band of approximately 660 bp was noted for all strains
regardless of the stx2 content; however, the nature and signif-
icance of this band is not known (data not shown). The re-
maining two strains contained only the stx1 gene. In contrast,
the stx2c variant was only detected in two of the 112 LSPA6-LI
strains (1.8%) and seven of 14 LSPA6-LI/II strains (50%)
(Table 4). The two LSPA6-LI strains contained both stx2c and
stx2. The difference in the carriage rates of stx2c between
LSPA6-LII strains and LSPA6-LI genotype strains was found
to be statistically significant (Fisher exact test; P  3.089 
1041). Although Stx2c has been reported to have the same
level of toxicity as Stx2 in mice (32), the risk of developing HUS
after infection with stx2c-containing STEC has been reported to
be significantly lower than with STEC possessing the stx2 toxin
genotype (14). This is also in agreement with other studies that
report that most HUS cases were associated with E. coli strains
carrying stx2 rather than other stx2 variant genes (6, 49).
Although it is possible that these Stx2 variants differ in tox-
icity for humans, it has been suggested that Stx2c-producing
strains simply produce less Stx (7, 12, 38). To determine
whether this was the case, Stx2 production by eight Stx2-pro-
ducing strains (seven LSPA6-LI strains and one LSAP6-LI/II
strain) and nine Stx2c-producing strains (all LSPA6-LII) was
quantified by an Stx-ELISA that reacts with all Stx2 variants.
Figure 3 shows the amount of toxin produced by selected
strains from LSPA6-LI, -LII, and -LI/II before and after in-
duction with mitomycin C. For five of the nine LSPA6-LII
Stx2c-producing strains, the amounts of toxin produced without
induction with mitomycin C were very low compared to other
LSAP6-LII strains and the Stx2-producing LSAP6-LI and LI/II
strains. Since the low-toxin-producing strains were from PTs 23
and 67 strains, an additional five PT 23 and five PT 67 strains
were tested by the Stx-ELISA. These strains also produced
very low levels of toxin and showed similar increases on induc-
tion with mitomycin C. Therefore, low production of Stx2c may
be more strongly associated with these PTs rather than strictly
with the LSPA6 genotype. Production of low levels of Stx2c by
O157:H7 strains of PT 23 and 67 may explain the infrequent
association of these PTs with human disease, and further stud-
ies should be performed to examine this relationship.
FIG. 1. Relationship between PT and LSPA6 genotype for the 187 E. coli O157:H7 strains in Table 1.
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Association between plasmid profiles and LSPA6 genotype.
Thirteen different plasmid profiles were observed among the
E. coli O157:H7 strains in set 1 (data not shown). Nine plas-
mids ranging in size from 70 to 2.2 MDa were identified in set
1 strains. All strains possessed the large 60-MDa pO157 viru-
lence plasmid and were PCR positive for the enterohemolysin
gene (hlyA). The two predominant profiles among these strains
were the presence of pO157 alone and pO157 combined with
FIG. 2. Relationship between source and LSPA6 genotype for the 187 E. coli O157:H7 strains in Table 1.
TABLE 4. Differences in the presence of cda, stx2c, and streptomycin, sulfisoxazole, and tetracycline antimicrobial resistance
among LSPA6 genotypes
Genotypea Origin nb
Presence ofc:
stx2c cda
Streptomycin, sulfisoxazole, and
tetracycline resistance
No.
positive
%
Positive SS
No.
positive
%
Positive SS
No.
positive
%
Positive SS
LSPA6-LI Bovine 53 1 1.9 a 15 28.3 a, c 1* 1.9 a
Human 59 1 1.7 a 11 18.6 a 0* 0 a
Total 112 2 1.8 a 26 23.2 a 1* 0.9 a
LSPA6-LI/II Bovine 5 4 80 b, c 1 20 a, b 0 0 a, b
Human 9 3 33.3 b 0 0 a 0 0 a
Total 14 7 50 b 1 7.1 a 0 0 a
LSPA6-LII Bovine 49 48 98 c 27 55.1 b 36† 73.5 c
Human 12 11 91.7 b, c 4 33.3 a, b 8† 66.7 b, c
Total 61 59 96.7 c 31 50.8 b, c 44† 72.1 c
a LSPA6-LI refers to LSPA6 genotype 111111, LSPA6-LI/II refers to LSPA6 genotype 211111, and LSPA6-LII refers to alllineage II-related LSPA6 genotypes.
b n, Number of samples examined.
c Statistical significance (SS) was evaluated at the P 0.01 level. Test groups of strains with the same letter designation did not have a statistically significant difference
in carriage rate for the specific trait (Fisher exact test, P  0.01), e.g., bovine LSPA6-L1 and human LSPA6-L1 do not have a significant difference in the presence of
cda, whereas bovine LSPA6-L1 and bovine LSPA-LII do. For the P values associated with the various pairwise comparisons, please refer to Tables S1, S2, and S3 in
the supplemental material. , one bovine and five human LSPA6-LI strains were resistant to single antibiotics or other combinations of antibiotics other than
streptomycin, sulfisoxazole, and tetracycline; †, all LSPA6-LII strains expressing AMR were resistant to streptomycin, sulfisoxazole, and tetracycline.
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a 2.2-MDa plasmid. These two profiles were observed in 56.9
and 15.3% of strains, respectively. The common occurrence of
the 2.2-MDa plasmid is in agreement with another study that
found this plasmid in 57% of O157 strains (51). In the present
study, only PTs 21, 31, 32, and 33 contained the 2.2-MDa
plasmid, and there appeared to be no bias in distribution
among human and nonhuman strains. Previously, a 2.2-MDa
plasmid, designated p4821, was characterized by Haarmann et
al. (18) and found to be similar to the antibiotic resistance
plasmid of Salmonella enterica serovar Typhimurium strains.
There did not appear to be any significant association between
specific plasmid profiles and LSPA6 genotype or isolate
source.
Association between colicins and LSPA6 genotype. E. coli
O157:H7 strains positive for the colicin D gene cda were found
in 26 of 112 (23.2%) LSPA6-LI strains, 1 of 14 (7.1%) LSPA6-
LI/II strains, and 31 of 61 (50.8%) LSPA6-LII strains (Table
4). The difference in cda carriage rates between LSPA6-LI and
LII strains was highly significant (Fisher exact test; P  3.427 
104). Interestingly, the cda gene was observed in only three
out of the eight LSPA6-LII-associated PTs (PTs 23, 45, and 67)
(Fig. 4), and carriage of cda was largely confined to certain
LSPA6-LI PTs (PTs 1, 4, and 8) as well. Therefore, it appears
that possession of cda may be more strongly associated with PT
than with the LSPA6 genotype.
Other colicins were found at a much lower frequency among
E. coli O157:H7 strains; e.g., one of 69 (1.4%) strains had
colicins B and M and two strains (2.8%) had colicin Ia/Ib (data
not shown). The higher prevalence of cda among the E. coli
O157:H7 strains is in agreement with the results of previous
reports (15, 51). As expected, all strains that contained the
4.6-Mda plasmid were found by PCR to possess the cda gene
(8, 21).
Colicins may offer a selective advantage to their host (45). In
FIG. 3. Stx2 or Stx2c production by selected E. coli O157:H7
strains.
FIG. 4. Relationship between PT and presence of cda for the 187 E. coli O157:H7 strains in Table 1.
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one study, pColD157 was identified in the majority of E. coli
O157:H7 strains associated with human disease (8). Another
study found that pColD157 was less prevalent in recent E. coli
O157:H7 isolates than those obtained several years previously
(21). Although interesting, the significance of a higher fre-
quency of cda in lineage II strains observed in the present study
is unknown. Since cda is not widespread among E. coli
O157:H7 strains, it does not appear to be essential, or perhaps
its function (or that of genetically linked genes) has been
replaced by some other attribute of the organism.
Association between AMR and LSPA6 genotype. Only 7.2%
(5 of 69) of the E. coli O157:H7 strains (set 1) selected from
the collection based on PT frequency displayed resistance to
one or more of the antibiotics tested. All of the resistant strains
from this initial set of strains had combined resistance to strep-
tomycin, sulfisoxazole, and tetracycline (AMR-SST) and one
AMR-SST bovine strain was also resistant to spectinomycin.
Other studies have also found that resistance to streptomycin,
sulfisoxazole, and tetracyclines is common in E. coli O157
strains (27, 34, 53, 56). Only 1 of the 37 human strains from set
1 displayed resistance to the antimicrobials tested, whereas 4 of
the 32 (12.5%) bovine strains showed AMR (data not shown).
Four of the five E. coli O157:H7 strains with AMR were of
LSPA6-LII genotypes and also of PTs 23, 45, and 67.
To determine whether any association exists between AMR
and LSPA6 genotype and/or PT, additional strains from each
PT were tested for AMR (Table 1). The results for all strains
indicated that within LSPA6-LII strains, 44 of 61 (72.1%) were
AMR-SST positive (Table 4) compared to only 1 of 112 (0.9%)
of the LSAP6-LI strains (Fisher exact test; P 7.536 1026).
For strains of LSPA6-LII-associated PTs, 24/25 PT 23, 11/11
PT 45, and 8/8 PT 67 strains were AMR-SST, whereas strains
of the LSPA6-LII-associated PTs, PT 54 and PT 74, had no
AMR. Based on these data it would seem that AMR-SST is
largely confined not only to LSPA6-LII strains but also to
specific PTs within this group (Fig. 5). Although it can be
argued that the strains in the collection may not be represen-
tative of these PTs from other geographical regions, Mora et
al. (34) have also recently reported an association between PT
23 E. coli O157:H7 strains and AMR-SST in Spain (34). It is
possible that AMR may play a role in the survival and persis-
tence of LSPA6-LII E. coli O157:H7 strains in the bovine
reservoir.
At 34.5%, the AMR prevalence in bovine strains in the
present study is similar to the rate observed in the United
States (33) but lower than the 65% AMR rate reported for E.
coli O157 strains from cattle in feedlots in Saskatchewan, Can-
ada (53), and the 53% AMR rate of E. coli O157 strains from
cattle in Spain (34). However, comparisons between studies
should consider differences in study design, strain selection,
geographic region, and scope of the study.
FIG. 5. Relationship between PT and combined antimicrobial resistance to streptomycin, sulfisoxazole, and tetracycline for the 187 E. coli
O157:H7 strains in Table 1.
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Conclusions. In our comparison of characteristics of LSPA6
genotypes and PTs of E. coli O157:H7 strains isolated from
Canadian sources, the majority of strains were genotype
LSPA6-LI, and smaller proportions belonged to the LSPA6-
LI/II and LSPA6-LII genotypes. One of the key findings was
that PTs 23, 45, 54, 67, and 74 were genotype LSPA6-LII
specific. As has previously been observed in O157:H7 strains
from the United States, LSPA6-LII genotypes were signifi-
cantly more likely to be isolated from cattle than from humans.
Certain genes, such as eaeA, were conserved across all lin-
eages and PTs (data not shown), whereas the stx2c variant toxin
was strongly associated with LSPA6-LII strains. In addition,
LSPA6-LII strains of PTs 23 and 67 produced lower levels of
toxin than strains from other PTs and LSPA6 genotypes within
lineage I and lineage II. E. coli O157:H7 strains of LSPA6-LII
were also significantly more likely to possess cda and have
AMR than LSPA6-LI and LSPA6-LI/II strains. Collectively,
our results imply that the two lineages of E. coli O157:H7
indeed have many unique physiological and ecological charac-
teristics that could influence their propensity to cause disease
or their ability to propagate in bovine production environ-
ments. Recent studies on E. coli genomes have highlighted the
importance of genomic island content in differentiating among
various E. coli serotypes and pathotypes (9, 20, 39, 41). Specific
sets of these large genetic elements presumably explain the
phenotypic differences among these E. coli groups in host ad-
aptation, pathogenesis, virulence, epidemiology, and ecology
(19, 24). Generation of new genotypes of E. coli O157:H7 is
therefore likely to be driven by the acquisition, rearrangement,
and loss of these genetic elements. However, it is interesting
that despite the apparent instability of these elements there is
also evidence of stable gene linkage (e.g., as parts of functional
units such as the LEE type III secretion system or genes of
related function such as multiple-antibiotic resistance) (17, 31).
The apparent stability within E. coli groups of certain of these
mobile multigene elements suggests that they have been re-
tained through the selection for one or more phenotypic traits
encoded by these genes. In addition, certain of these elements
may act to exclude the uptake of other mobile genetic elements
through mechanisms such as plasmid incompatibility, changes
in phage receptors, and phage-related immunity to superinfec-
tion with other bacteriophages (13, 22) and thereby contribute
to genotypic and phenotypic stability of the organism. Link-
ages of LSPA6 typing markers to genes encoding phenotypic
characteristics observed in the present study appear to be
indirect. It is important to note that the markers targeted by
the LSPA6 assay were selected because they are expected to
be selectively neutral (54). The differential association of
the various phenotypic traits that were tested in the present
study (colicin production, AMR, toxin production, and PT)
with neutral lineage-specific markers would suggest that cer-
tain combinations of these traits arose early in the diver-
gence of the two lineages and that these combinations have
remained stable over time. It is possible that geographical or
niche isolation may also have played a role in maintaining
relatively fixed constellations of genes in certain populations
of E. coli O157:H7 and helped create some of the lineage-
specific phenotypes observed in the present study.
Further study of E. coli O157:H7 strains from other geo-
graphical regions is needed to determine whether the associ-
ations between LSPA6 genotype, PT, and other phenotypic
characteristics observed in the present study are widely appli-
cable.
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